Kampala, Uganda | THE INDEPENDENT | A phase three COVID-19 vaccine trial by global company Johnson and Johnson involving 60,000 participants has been halted after a participant fell inexplicably ill. According to a statement, the study that only launched last month has been temporarily halted as they evaluate the patient’s …
Read More »